StockIQpro
NASDAQ:REPL

Replimune Group, Inc.

Track all markets on TradingView
Track all markets on TradingView

Replimune Group, Inc. reported net income of −$313.9M in fiscal 2026. Free cash flow was −$284.6M, and the diluted share count rose 15.2%.Summary generated from Replimune Group, Inc.'s SEC filings. Latest annual report filed Jun 29, 2026.

Key statistics

Fiscal 2026 from SEC filings. Methodology
Revenue (FY26)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROIC−129.1%
Return on equity−107.9%
Debt / equity0.50
Free cash flow−$284.6M
FCF marginn/a
Share count change+15.2%

Financials

Fiscal years, $M
Item20222023202420252026
Revenuen/an/an/an/an/a
Operating income−118−177−235−262−320
Net income−118−174−216−247−314
Free cash flow−85−130−191−199−285

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)